Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
WorkCompWire
Article
3 For NWCDC: Pat Chavanu of Genex Services
During our time at NWCDC 2015, we had Workers’ Comp industry stakeholders participate in WorkCompWire’s “3 For NWCDC” series, focused on this year’s developments and on improving the system! Here’s what Pat Chavanu, Senior Vice President, National Accounts at Genex Services had to say:
Download Now
Article
360 Data Analysis Checklist
Business Insurance
In the News
Networking pays off
Employers who partner closely with doctors see improved outcomes in workers’ compensation claims. This article explores how collaboration, communication, and early intervention are key to enhancing recovery times and reducing claim costs.
Risk & Insurance
In the News
The PBM Evolution
Explore how evolving PBM models are improving transparency, outcomes, and cost control in this in-depth feature from Risk & Insurance.
Workers' Comp
Article
StateWatch Winter 2015
PC 360
Article
Property Casualty 360: 6 best practices for case managers
Cutting costs no matter what is not the way to do the job.